Oklahoma's attorney general has accused CVS's Caremark pharmacy benefit manager unit of under-reimbursing pharmacies for ...

As the rising cost of insulin continues to make it difficult for so many diabetic patients to receive life-saving care, ...

Discover how the three largest pharmacy benefit managers are rejecting biosimilars from their formularies, except for their own private-label drugs.

The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.

CVS Health's Caremark, Cigna-owned Express Scripts and UnitedHealth's Optum Rx. The association said regulating the PBMs would save taxpayers $5 billion. "We are up against these giant ...

FTC stated that the 'Big 3' PBM organisations collectively generated over £5.94 billion ($7.3 billion) in revenue from 2017 to 2022.

the big three players in the sector – CVS' Caremark, Cigna's Express Scripts, and UnitedHealth's OptumRx. It concludes that the PBMs generated $7.3 billion by marking up drugs in these ...

And this year CVS’s Caremark is rolling out simplified drug ... Express Scripts ranked No. 25 on the Fortune 500 in 2018, the year Cigna acquired it. It's now part of Cigna's $153.5 billion ...

Unions that provide health benefits to nearly a half-million workers — including many in Ohio — have filed nearly identical ...